Zurich Cantonal Bank’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.6K | Buy |
7,455
+3,591
| +93% | +$10K | ﹤0.01% | 2477 |
|
|
2026
Q1 | $10.6K | Buy |
3,864
+368
| +11% | +$1.17K | ﹤0.01% | 2482 |
|
|
2025
Q4 | $12.9K | Hold |
3,496
| – | – | ﹤0.01% | 2475 |
|
|
2025
Q3 | $9.26K | Sell |
3,496
-2,586
| -43% | -$5K | ﹤0.01% | 2502 |
|
|
2025
Q2 | $5.99K | Hold |
6,082
| – | – | ﹤0.01% | 2533 |
|
|
2025
Q1 | $8.76K | Buy |
+6,082
| New | +$11.2K | ﹤0.01% | 2596 |
|
|
2023
Q2 | – | Sell |
-11,970
| Closed | -$19K | – | 2817 |
|
|
2023
Q1 | $19K | Hold |
11,970
| – | – | ﹤0.01% | 2759 |
|
|
2022
Q4 | $74.6K | Buy |
+11,970
| New | +$85.6K | ﹤0.01% | 2447 |
|
|
2021
Q4 | – | Sell |
-2,941
| Closed | -$35K | – | 2914 |
|
|
2021
Q3 | $35K | Hold |
2,941
| – | – | ﹤0.01% | 2713 |
|
|
2021
Q2 | $62K | Hold |
2,941
| – | – | ﹤0.01% | 2395 |
|
|
2021
Q1 | $82K | Hold |
2,941
| – | – | ﹤0.01% | 2231 |
|
|
2020
Q4 | $76K | Hold |
2,941
| – | – | ﹤0.01% | 2319 |
|
|
2020
Q3 | $109K | Hold |
2,941
| – | – | ﹤0.01% | 1942 |
|
|
2020
Q2 | $151K | Buy |
2,941
+782
| +36% | +$32.7K | ﹤0.01% | 1711 |
|
|
2020
Q1 | $68K | Buy |
2,159
+808
| +60% | +$42.6K | ﹤0.01% | 1803 |
|
|
2019
Q4 | $81K | Hold |
1,351
| – | – | ﹤0.01% | 1851 |
|
|
2019
Q3 | $50K | Hold |
1,351
| – | – | ﹤0.01% | 2045 |
|
|
2019
Q2 | $63K | Hold |
1,351
| – | – | ﹤0.01% | 1915 |
|
|
2019
Q1 | $54K | Hold |
1,351
| – | – | ﹤0.01% | 1946 |
|
|
2018
Q4 | $62K | Hold |
1,351
| – | – | ﹤0.01% | 1895 |
|
|
2018
Q3 | $60K | Buy |
1,351
+183
| +16% | +$8.4K | ﹤0.01% | 2040 |
|
|
2018
Q2 | $46K | Hold |
1,168
| – | – | ﹤0.01% | 2179 |
|
|
2018
Q1 | $84K | Hold |
1,168
| – | – | ﹤0.01% | 1707 |
|
|
2017
Q4 | $77K | Buy |
1,168
+374
| +47% | +$20.1K | ﹤0.01% | 1742 |
|
|
2017
Q3 | $40K | Buy |
794
+288
| +57% | +$13.9K | ﹤0.01% | 1943 |
|
|
2017
Q2 | $23K | Hold |
506
| – | – | ﹤0.01% | 2198 |
|
|
2017
Q1 | $18K | Hold |
506
| – | – | ﹤0.01% | 2334 |
|
|
2016
Q4 | $6K | Hold |
506
| – | – | ﹤0.01% | 2513 |
|
|
2016
Q3 | $7K | Hold |
506
| – | – | ﹤0.01% | 2469 |
|
|
2016
Q2 | $5K | Hold |
506
| – | – | ﹤0.01% | 2491 |
|
|
2016
Q1 | $9K | Hold |
506
| – | – | ﹤0.01% | 2383 |
|
|
2015
Q4 | $11K | Buy |
506
+279
| +123% | +$7.04K | ﹤0.01% | 2334 |
|
|
2015
Q3 | $5K | Buy |
227
+64
| +39% | +$4.02K | ﹤0.01% | 2394 |
|
|
2015
Q2 | $13K | Buy |
163
+63
| +63% | +$6.17K | ﹤0.01% | 1247 |
|
|
2015
Q1 | $9K | Buy |
+100
| New | +$6.45K | ﹤0.01% | 1425 |
|
Other funds holding ESPR
GCL
TC
AA
OBAM
Zurich Cantonal Bank's ESPR Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Esperion Therapeutics (ESPR) stake by 93% in Q2 2026, buying an estimated $10K and bringing the position to 7,455 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.
Zurich Cantonal Bank first reported a position in ESPR in Q1 2015 and has held it in 35 quarters since. The position peaked at $151K in Q2 2020. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.
- Zurich Cantonal Bank held 7,455 shares of Esperion Therapeutics worth $23.6K as of Q2 2026.
- Zurich Cantonal Bank bought 3,591 Esperion Therapeutics shares in Q2 2026, an estimated $10K.
- Esperion Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2477 holding.
- Zurich Cantonal Bank first reported a position in Esperion Therapeutics in Q1 2015 and has held it in 35 quarters since.
- Zurich Cantonal Bank's Esperion Therapeutics position peaked at $151K in Q2 2020.
- 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.